AR-1008

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAR-1008
Drug Alias NameAR-1008
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1
Therapy Area/IndicationsObesityMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAribio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAribio Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A